Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | -268.22%-2.63M | -62.85%381.17K | 74.13%-342K | -280.35%-2.55M | -126.52%-118K | 3.75%1.56M | 268.01%1.03M | -227.24%-1.32M | -56.89%1.42M | 120.20%445K |
| Net profit before non-cash adjustment | 106.76%20.93K | 222.71%633.93K | 486.54%305K | -801.15%-610K | -552.94%-308K | -106.50%-309.6K | -125.07%-516.6K | -33.33%52K | -85.97%87K | -96.61%68K |
| Total adjustment of non-cash items | 106.55%56.22K | 76.29%-299.78K | 234.78%154K | -40.96%111K | -47.09%91K | 49.13%-858.51K | 45.97%-1.26M | -83.15%46K | -1.57%188K | -8.99%172K |
| -Depreciation and amortization | 16.95%1.03M | 67.51%369.97K | -0.91%218K | 0.00%221K | 0.92%220K | 12.90%879.86K | -1.11%220.86K | 5.26%220K | 33.13%221K | 20.44%218K |
| -Reversal of impairment losses recognized in profit and loss | 590.56%28.4K | ---- | ---- | ---- | ---- | --4.11K | ---- | ---- | ---- | ---- |
| -Assets reserve and write-off | --28K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Disposal profit | 22.78%-1.39M | 42.17%-868.22K | -9.52%-207K | -258.00%-179K | -115.38%-140K | 29.62%-1.81M | 41.47%-1.5M | ---189K | ---50K | ---65K |
| -Other non-cash items | 524.75%393.07K | 1,327.23%170.07K | 853.33%143K | 305.88%69K | -42.11%11K | -35.92%62.92K | 907.27%11.92K | -76.56%15K | -32.00%17K | 137.50%19K |
| Changes in working capital | -199.12%-2.71M | -98.32%47.03K | 43.59%-801K | -280.09%-2.05M | -51.71%99K | 274.26%2.73M | 948.49%2.81M | -306.40%-1.42M | -53.86%1.14M | 104.66%205K |
| -Change in receivables | -627.95%-3.45M | -164.80%-956.16K | 43.53%-960K | -222.27%-1.22M | -158.33%-310K | 129.41%652.56K | 237.46%1.48M | -398.25%-1.7M | -60.31%997K | 97.16%-120K |
| -Change in payables | -64.55%737.19K | -24.66%1M | -43.21%159K | -683.22%-834K | 25.85%409K | 219.61%2.08M | 79.29%1.33M | 137.29%280K | 448.78%143K | 292.31%325K |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | -524.75%-393.07K | -1,327.23%-170.07K | -853.33%-143K | -305.88%-69K | 42.11%-11K | 14.41%-62.92K | 17.88%-11.92K | 55.88%-15K | -54.55%-17K | -35.71%-19K |
| Interest received (cash flow from operating activities) | 0 | |||||||||
| Tax refund paid | 94.82%-22.93K | -76.22%-76.93K | 10.81%-33K | 207.14%150K | 71.62%-63K | 69.36%-442.65K | 84.94%-43.65K | 88.22%-37K | 43.09%-140K | 62.69%-222K |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | -387.88%-3.05M | -86.17%134.18K | 62.30%-518K | -296.42%-2.47M | -194.12%-192K | 11,381.63%1.06M | 207.61%970.38K | -298.84%-1.37M | -58.43%1.26M | 107.27%204K |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | 72.61%-8.89K | -563.22%-2.89K | --0 | 76.92%-6K | --0 | 96.79%-32.44K | 97.00%-435 | --0 | 96.94%-26K | 80.65%-6K |
| Net business purchase and sale | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net investment product transactions | 116.26%70K | --0 | --0 | --0 | -63.16%70K | 87.70%-430.54K | ---966.54K | --164K | 105.20%182K | --190K |
| Investing cash flow | 113.20%61.12K | 99.70%-2.89K | --0 | -103.85%-6K | -61.96%70K | 89.67%-462.97K | -406.49%-966.97K | 139.52%164K | 103.59%156K | 693.55%184K |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | --3M | --0 | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net common stock issuance | --400K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net preferred stock issuance | --400K | --0 | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Increase or decrease of lease financing | -32.73%-657.75K | -109.11%-266.75K | -5.60%-132K | -6.50%-131K | -6.67%-128K | -13.33%-495.56K | -1.02%-127.56K | -19.05%-125K | -12.84%-123K | -23.71%-120K |
| Net other fund-raising expenses | 761.49%500K | ---- | ---- | ---- | ---- | 158.04%58.04K | ---- | ---- | ---- | ---- |
| Financing cash flow | 841.04%3.24M | 435.50%233.26K | 314.40%268K | 2,432.52%2.87M | -6.67%-128K | -84.40%-437.53K | -194.30%-69.53K | -19.05%-125K | -12.84%-123K | -23.71%-120K |
| Net cash flow | ||||||||||
| Beginning cash position | 91.07%331.24K | -43.83%223K | -72.69%473K | -81.63%81K | 91.33%331K | -96.45%173.36K | -44.94%397K | 214.91%1.73M | -77.76%441K | -96.48%173K |
| Current changes in cash | 62.50%256.55K | 651.33%364.55K | 81.27%-250K | -69.64%392K | -193.28%-250K | 103.35%157.88K | 87.10%-66.12K | -880.70%-1.34M | 190.09%1.29M | 109.13%268K |
| End cash Position | 77.45%587.79K | 77.45%587.79K | -43.83%223K | -72.69%473K | -81.63%81K | 91.07%331.24K | 91.07%331.24K | -44.94%397K | 214.91%1.73M | -77.76%441K |
| Free cash flow | -397.84%-3.06M | -86.46%131.29K | 62.30%-518K | -301.06%-2.48M | -196.97%-192K | 202.46%1.03M | 257.39%969.94K | -597.83%-1.37M | -43.38%1.23M | 106.98%198K |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.